Becton, Dickinson and Company (NYSE:BDX) Q2 2023 Earnings Call Transcript
Operator: Good day everyone and welcome to today’s Becton, Dickinson Q2 Fiscal Year 2023 Earnings Call. At the time, all participants are in a listen-only mode.
Stay updated with breaking news from Cellview Image Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day everyone and welcome to today’s Becton, Dickinson Q2 Fiscal Year 2023 Earnings Call. At the time, all participants are in a listen-only mode.
/PRNewswire/ -- The "Cell and Gene Therapy Biomanufacturing Market - A Global and Regional Analysis: Focus on Product Type, Application, Usage, End-user, and...
/PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Cell and Gene...
The firm has developed a technology to sort cells based on 11 non-fluorescent parameters and process up to one million cells per minute.